RUTHERFORD, N.J., Sept. 9, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics that personalizes the diagnosis and prediction of treatment outcomes for difficult to diagnose cancers, today announced executives from the company will participate at the following investor conferences in September:
Help employers find you! Check out all the jobs and post your resume.
